2-[4-(2,4-dihexoxyphenyl)phenyl]-7-(2,4-dimethylphenyl)-1-heptan-3-ylindolizine
C47H61NO2 — CID 130310533
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-(2,4-dihexoxyphenyl)phenyl]-7-(2,4-dimethylphenyl)-1-heptan-3-ylindolizine
2-[4-(2,4-dihexoxyphenyl)phenyl]-7-(2,4-dimethylphenyl)-1-heptan-3-ylindolizine (PubChem CID 130310533) has the molecular formula C47H61NO2 and a molecular weight of 672.01 g/mol. Its IUPAC name is 2-[4-(2,4-dihexoxyphenyl)phenyl]-7-(2,4-dimethylphenyl)-1-heptan-3-ylindolizine.
Molecular Properties
| Compound Name | 2-[4-(2,4-dihexoxyphenyl)phenyl]-7-(2,4-dimethylphenyl)-1-heptan-3-ylindolizine |
|---|---|
| PubChem CID | 130310533 |
| Molecular Formula | C47H61NO2 |
| Molecular Weight | 672.01 g/mol |
| Exact Mass | 671.47 |
| IUPAC Name | 2-[4-(2,4-dihexoxyphenyl)phenyl]-7-(2,4-dimethylphenyl)-1-heptan-3-ylindolizine |
| SMILES | CCCCCCOc1ccc(-c2ccc(-c3cn4ccc(-c5ccc(C)cc5C)cc4c3C(CC)CCCC)cc2)c(OCCCCCC)c1 |
| InChI | InChI=1S/C47H61NO2/c1-7-11-14-16-29-49-41-24-26-43(46(33-41)50-30-17-15-12-8-2)38-20-22-39(23-21-38)44-34-48-28-27-40(42-25-19-35(5)31-36(42)6)32-45(48)47(44)37(10-4)18-13-9-3/h19-28,31-34,37H,7-18,29-30H2,1-6H3 |
| InChIKey | WYWVTPURGRWQGU-UHFFFAOYSA-N |
| XLogP | 14.16 |
| TPSA | 22.87 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 20 |
| Heavy Atoms | 50 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 672.01 |
| LogP ≤ 5 | 14.16 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 130310533 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.